UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times

The European respiratory journal, 2018-06, Vol.51 (6), p.1800602-1800602

Uguen, Arnaud

2018

Volltextzugriff (PDF)

Idylla MSI test combined with immunohistochemistry is a valuable and cost effective strategy to search for microsatellite instable tumors of noncolorectal origin

Pathology international, 2022-04, Vol.72 (4), p.234-241

2022

Volltextzugriff (PDF)

About RAS mutation–specific immunohistochemistry in formalin-fixed paraffin-embedded tumor samples

Human pathology, 2017-02, Vol.60, p.208-209

Uguen, Arnaud, MD, PhD

2017

Volltextzugriff (PDF)

Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma

Nature communications, 2023-12, Vol.14 (1), p.8290-8290, Article 8290

2023

Volltextzugriff (PDF)

Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation

Oncogene, 2022-04, Vol.41 (18), p.2571-2586

2022

Volltextzugriff (PDF)

Decalcification can cause the failure of BRAF molecular analyses and anti‐BRAFV600E VE1 immunohistochemistry

Pathology international, 2019-04, Vol.69 (4), p.219-223

2019

Volltextzugriff (PDF)

Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?

Cancers, 2023-05, Vol.15 (10), p.2768

2023

Volltextzugriff (PDF)

A gene expression and pre-mRNA splicing signature that marks the adenoma-adenocarcinoma progression in colorectal cancer

PloS one, 2014-02, Vol.9 (2), p.e87761-e87761

2014

Volltextzugriff (PDF)

A review on the Idylla platform: towards the assessment of actionable genomic alterations in one day

Journal of clinical pathology, 2018-09, Vol.71 (9), p.757-762

2018

Volltextzugriff (PDF)

The Usefulness of SP174 Anti-RASQ61R Immunohistochemistry in Melanoma, Thyroid, and Colorectal Cancers

Archives of pathology & laboratory medicine (1976), 2017-12, Vol.141 (12), p.1601-1601

Uguen, Arnaud

2017

Volltextzugriff (PDF)

Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors

Virchows Archiv : an international journal of pathology, 2015-07, Vol.467 (1), p.47-54

2015

Volltextzugriff (PDF)

ROS1 fusions in cancer: a review

Future Oncology, 2016-08, Vol.12 (16), p.1911-1928

2016

Volltextzugriff (PDF)

Microsatellite instability diagnosis using the fully automated Idylla platform: feasibility study of an in-house rapid molecular testing ancillary to immunohistochemistry in pathology laboratories

Journal of clinical pathology, 2019-12, Vol.72 (12), p.830-835

2019

Volltextzugriff (PDF)

Performances of the Idylla GeneFusion Assay: contribution to a rapid diagnosis of targetable gene fusions in tumour samples

Journal of clinical pathology, 2024-08, Vol.77 (8), p.561-567

2024

Volltextzugriff (PDF)

Reasons for pathologic examination of sleeve gastrectomy remnants in France

The American journal of surgery, 2018-11, Vol.216 (5), p.1031-1032

2018

Volltextzugriff (PDF)

MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories

Human pathology, 2021-08, Vol.114, p.99-109

2021

Volltextzugriff (PDF)

Breast cancer tumor heterogeneity has only little impact on the estimation of the Oncotype DX® recurrence score using Magee Equations and Magee Decision Algorithm

Human pathology, 2021-02, Vol.108, p.51-59

2021

Volltextzugriff (PDF)

Targeting BRAF mutants in clear-cell sarcomas of soft tissue: beyond sarcoma or melanoma classification

Investigational new drugs, 2016-04, Vol.34 (2), p.253-254

2016

Volltextzugriff (PDF)

Evaluation of KRAS, NRAS and BRAF mutational status and microsatellite instability in early colorectal carcinomas invading the submucosa (pT1): towards an in-house molecular prognostication for pathologists?

Journal of clinical pathology, 2020-11, Vol.73 (11), p.741-747

2020

Volltextzugriff (PDF)

Testing for BRAF fusions in patients with advanced BRAF/NRAS/KIT wild-type melanomas permits to identify patients who could benefit of anti-MEK targeted therapy

Journal of clinical pathology, 2020-02, Vol.73 (2), p.116-119

2020

Volltextzugriff (PDF)

Mismatch repair–deficient colorectal cancer: a model of immunogenic and immune cell–rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells

Human pathology, 2018-02, Vol.72, p.135-143

2018

Volltextzugriff (PDF)

Fluorescence in situ hybridization testing of chromosomes 6, 8, 9 and 11 in melanocytic tumors is difficult to automate and reveals tumor heterogeneity in melanomas

Oncology letters, 2016-10, Vol.12 (4), p.2734-2741

2016

Volltextzugriff (PDF)

ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issues

Oncology reports, 2016-09, Vol.36 (3), p.1427-1434

2016

Volltextzugriff (PDF)

Identification of a novel population in high-grade oligodendroglial tumors not deleted on 1p/19q using array CGH

Journal of neuro-oncology, 2012-09, Vol.109 (2), p.405-413

2012

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

KollektionWK Lippincott Williams & Wilkins–Connect here FIRST to enable access

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times

Idylla MSI test combined with immunohistochemistry is a valuable and cost effective strategy to search for microsatellite instable tumors of noncolorectal origin

About RAS mutation–specific immunohistochemistry in formalin-fixed paraffin-embedded tumor samples

Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma

Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation

Decalcification can cause the failure of BRAF molecular analyses and anti‐BRAFV600E VE1 immunohistochemistry

Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?

A gene expression and pre-mRNA splicing signature that marks the adenoma-adenocarcinoma progression in colorectal cancer

A review on the Idylla platform: towards the assessment of actionable genomic alterations in one day

The Usefulness of SP174 Anti-RASQ61R Immunohistochemistry in Melanoma, Thyroid, and Colorectal Cancers

Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors

ROS1 fusions in cancer: a review

Microsatellite instability diagnosis using the fully automated Idylla platform: feasibility study of an in-house rapid molecular testing ancillary to immunohistochemistry in pathology laboratories

Performances of the Idylla GeneFusion Assay: contribution to a rapid diagnosis of targetable gene fusions in tumour samples

Reasons for pathologic examination of sleeve gastrectomy remnants in France

MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories

Breast cancer tumor heterogeneity has only little impact on the estimation of the Oncotype DX® recurrence score using Magee Equations and Magee Decision Algorithm

Targeting BRAF mutants in clear-cell sarcomas of soft tissue: beyond sarcoma or melanoma classification

Evaluation of KRAS, NRAS and BRAF mutational status and microsatellite instability in early colorectal carcinomas invading the submucosa (pT1): towards an in-house molecular prognostication for pathologists?

Testing for BRAF fusions in patients with advanced BRAF/NRAS/KIT wild-type melanomas permits to identify patients who could benefit of anti-MEK targeted therapy

Mismatch repair–deficient colorectal cancer: a model of immunogenic and immune cell–rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells

Fluorescence in situ hybridization testing of chromosomes 6, 8, 9 and 11 in melanocytic tumors is difficult to automate and reveals tumor heterogeneity in melanomas

ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issues

Identification of a novel population in high-grade oligodendroglial tumors not deleted on 1p/19q using array CGH

Aktive Filter

Suchergebnisse filtern